CION Cancer Clinics
Alpha-1 antitrypsin deficiency: what it means for your liver | CION Cancer Clinics
Alpha-1 antitrypsin deficiency can raise the risk of liver cancer, mostly once it has scarred the liver into cirrhosis. Many people with the condition never develop cancer. This page explains what the condition does to the liver, which types carry the most risk, how it is tested, and when regular surveillance scans make sense for you or your family. At CION Cancer Clinics, our specialists help you understand your own risk and plan regular liver checks that fit it.
On this page
- Does alpha-1 antitrypsin deficiency cause liver cancer?
- Who with alpha-1 antitrypsin deficiency is actually at risk?
- How is alpha-1 antitrypsin deficiency diagnosed and checked?
- What do the words on an alpha-1 report mean?
- What do families often get wrong about alpha-1 and the liver?
- What this page cannot tell you
- Common questions about alpha-1 antitrypsin deficiency and liver cancer
The short answer
Does alpha-1 antitrypsin deficiency cause liver cancer?
It can raise the risk, mainly in people whose liver has already been scarred by it. Alpha-1 antitrypsin deficiency is an inherited condition that can damage the liver slowly over many years, and a scarred liver is the soil in which liver cancer most often grows.
What the condition actually is
Alpha-1 antitrypsin is a protein made in the liver. Its job is to travel in the blood and protect the lungs from the body's own cleaning enzymes. In this condition a faulty gene makes a misshapen version of the protein. Much of it gets stuck inside the liver cells that made it, and the build-up injures them. The lungs, meanwhile, are left with too little protection.
Which liver cancer this page is about
This page is about primary liver cancer, which starts in the liver itself, usually hepatocellular carcinoma (HCC). If a scan has shown a spot in the liver that came from cancer somewhere else, that is a different illness with a different plan. Read about other inherited conditions that raise liver cancer risk if you are comparing.
Carrying the gene is not a cancer diagnosis. Many people with this condition never develop liver cancer.Not everyone the same
Who with alpha-1 antitrypsin deficiency is actually at risk?
The gene comes in several forms, and the liver risk depends heavily on which ones you inherited and what else your liver has been through.
Two faulty copies
People who inherit the faulty gene from both parents, often written as the ZZ type on a report, carry the clearest liver risk. Some show liver trouble as babies, with prolonged jaundice. Others feel well for decades and develop scarring in adult life.
One faulty copy
A person with one faulty copy and one normal copy is a carrier, sometimes written as MZ. On its own this usually causes little trouble. It seems to matter more when something else is also hurting the liver.
Things that add to the load
- Regular alcohol
- Fatty liver and excess weight
- Hepatitis B or C
Anyone who already has cirrhosis
Once the liver is scarred into cirrhosis, the cancer risk is driven mostly by the cirrhosis itself. From that point you are treated like anyone else with cirrhosis, which means regular surveillance scans.
People with lung disease only
Many people are diagnosed because of early emphysema or breathlessness, not liver problems. Their liver still deserves a check, because lung and liver damage do not always appear together.
Not sure whether this applies to you?
Ask an oncologistGetting an answer
How is alpha-1 antitrypsin deficiency diagnosed and checked?
A simple blood level
The first test measures how much alpha-1 antitrypsin is in your blood. A low level raises the question. A normal level does not always settle it, because illness and infection can push the level up for a while.
A type or gene test
A second blood test identifies which forms of the protein or gene you carry. This is what tells the doctor whether you have two faulty copies, one, or none, and it is what relatives can later be tested for.
Checking the liver itself
Liver blood tests, an ultrasound and often a stiffness scan (elastography, sometimes called FibroScan) show how much scarring there is. CION arranges these through diagnostic partners. Occasionally a liver biopsy is needed, and the protein can be seen trapped inside the cells under a microscope.
Deciding on surveillance
If there is cirrhosis, you will be advised to have an ultrasound, often with an AFP blood test, every six months. Read why the interval is six months and what the scan looks for.
On your report
What do the words on an alpha-1 report mean?
- AAT or A1AT
- Short forms of alpha-1 antitrypsin, the protein itself. A report may give its level in your blood.
- Phenotype or genotype
- Which versions of the protein or gene you carry. Letters such as M, S and Z name the versions. M is the usual, healthy one.
- PiZZ, PiMZ, PiSZ
- Two letters, one from each parent. ZZ means two faulty copies. MZ means one faulty and one normal. SZ sits in between.
- Fibrosis
- Early scarring in the liver. It can stay stable for a long time, especially if other strains on the liver are removed.
- Cirrhosis
- Heavy, widespread scarring that changes how the liver is built and how well it works. Read what cirrhosis is in plain words.
- AFP
- Alpha-fetoprotein, a blood marker sometimes used alongside the ultrasound in surveillance. It is a different protein from alpha-1 antitrypsin, despite the similar name.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often get wrong about alpha-1 and the liver?
The same faulty protein harms both organs in different ways. The lungs suffer from too little of it in the blood. The liver suffers from too much of it stuck inside its cells. Either can be affected without the other.
They do not. Replacing the protein in the blood helps the lungs in selected people, but it does nothing for the protein already trapped in the liver. Liver care is a separate plan, and these infusions are not easily available in India.
It is better described in European families, but it does occur in India and is probably missed often, because few people are tested. Unexplained liver disease or early emphysema in a non-smoker is a reason to ask.
Nobody chooses the genes they pass on, and most parents of an affected child had no idea they were carriers. The useful response is to test brothers and sisters, not to look for blame.
Being straight with you
What this page cannot tell you
It cannot tell you how scarred your own liver is or whether you need surveillance. That depends on your type, your scans, your blood tests and everything else your liver has met. A hepatologist or a physician who knows the condition is the right person to judge it, and they will look at the whole picture rather than the gene alone.
Who this does not apply to
If you have a normal level and a normal type, this condition is not part of your story. If you are a carrier with healthy liver tests, no alcohol use and no fatty liver, your liver risk is usually small. This page also does not cover lung treatment, which belongs with a chest physician.
Where CION fits
If a liver lesion has been found, or cancer has been diagnosed in someone with this condition, CION's tumour board reviews the scans and plans treatment alongside the hepatology team. Liver transplant, where it is considered, happens at licensed transplant centres. If you want to understand the genetics for your family, the cancer genetics guide explains how inherited faults work.
Bring every report you have, including any old childhood records of jaundice. They often help more than a new test.Questions we are asked
Common questions about alpha-1 antitrypsin deficiency and liver cancer
Will I definitely get liver cancer if I have alpha-1 antitrypsin deficiency?
No. Most people with the condition never develop liver cancer. The risk rises mainly once there is advanced scarring. What the diagnosis does is tell your doctor to keep an eye on your liver, and to start regular scans if cirrhosis develops.
Can liver cancer happen without cirrhosis in this condition?
It has been reported, but it is uncommon, and the evidence is thin. Most liver cancers in people with this condition arise in a liver that is already scarred. Your doctor may still suggest periodic checks if your liver tests are abnormal, even without cirrhosis.
Is there a treatment for the liver damage itself?
There is no medicine yet that clears the trapped protein from the liver, although several are being studied in trials. Care focuses on protecting the liver from extra harm and watching for complications. For people whose liver fails, a transplant gives them a liver that makes the normal protein.
Should my brothers, sisters and children be tested?
It is usually sensible, because the gene is shared in families and a simple blood test answers the question. Knowing early lets a relative avoid smoking, keep alcohol away and get the liver checked. A genetic counsellor or your doctor can explain what each result would mean before anyone is tested.
Does alcohol matter if I only carry one faulty copy?
It seems to. Carriers who also drink, or who have fatty liver, appear more likely to develop scarring than carriers who do not. The safest advice is to keep alcohol very low or stop. Tell your doctor honestly how much you drink, so the advice fits you.
Why does smoking matter if this page is about the liver?
Because the same condition leaves the lungs poorly protected, and smoking damages them much faster than usual. Smoking also adds to cancer risk generally. Stopping smoking is one of the most useful things anyone with this condition can do, whatever their liver looks like.
If liver cancer is found, is it treated differently?
Usually not. The team plans treatment on the size and spread of the tumour, how well the liver is working and how fit you are, as for anyone with HCC. The condition matters mainly because it affects liver function and lung health, which shape the options.
Where do I start if I have just been told I have this?
Ask for your type to be confirmed, a liver assessment and a lung check. Keep copies of every report. If you are unsure who to see, or a liver lesion has already been found, call the CION helpline and someone will guide you to the right clinic.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Liver Cancer Risk Factors
- Cancer Research UK — Risks and causes of liver cancer
- MedlinePlus — Cirrhosis
- National Cancer Institute — Liver Cancer Screening
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Told you have alpha-1 and want your liver checked properly?
Tell us what your reports say and we will help you understand them and plan the right liver checks. One helpline serves every CION centre.